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Reperfusion following ischemia is associated with acute
kidney injury and inflammation. Using a mouse model, we
exposed the kidney to a nonlethal period of ischemia,
rendering it refractory to future ischemia-induced
dysfunction. This ischemic preconditioning is partially
mediated by Treg lymphocytes that suppress immune
responses. We found that this maneuver significantly
inhibited the accumulation of neutrophils and macrophages,
tubular necrosis, and loss of kidney function caused by a
subsequent ischemia/reperfusion injury 1 week later. The
initial ischemia/reperfusion caused a significant increase in
CD4þCD25þFoxP3þ and CD4þCD25þ IL-10þ Treg cells
within the kidney at 7 days of reperfusion. Treatment of
preconditioned mice with a Treg cell–depleting antibody
(PC61) reversed the effect of preconditioning on kidney
neutrophil accumulation and partially inhibited the
functional and histological protection of preconditioning.
Adoptive transfer of Treg cells in naive mice, before ischemia/
reperfusion, mimicked the protective and anti-inflammatory
effects of ischemic preconditioning on the kidney. These
studies highlight the role of Treg cells in ischemic
preconditioning.
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Acute kidney injury is associated with high morbidity and
mortality and can predispose individuals to end-stage renal
disease.1 Ischemia/reperfusion injury (IRI) is a major cause of
acute kidney injury. Although the pathogenesis of IRI is
multifactorial, inflammation in the post-ischemic kidney
has been well established as a detrimental process in the
pathogenesis of kidney IRI.2–7 The innate immune response
to IRI involves the activation and accumulation of neutro-
phils and macrophages in the post-ischemic kidney, and
depletion of neutrophils or macrophages in mouse models
is sufficient to preserve kidney function after IRI.5–10
Similar to the heart, the kidney has the ability to be
preconditioned by a nonlethal period of ischemia, rendering
the kidney refractory to further ischemia-induced dysfunc-
tion (ischemic preconditioning, IPC11–14). Kidney IPC leads
to increased renal pro-survival signals: HSP 27 expression14
and Akt phosphorylation,13 and decreased phosphorylation
of cell-death-promoting p38 and Jun kinase.14 In addition,
adenosine receptor activation or inhibition mimics or
prevents the protective effect of IPC, respectively.12,13
Important studies recently showed that adoptive transfer
of kidney lymphocytes from preconditioned mice to non-
preconditioned recipients confers protection from kidney
IRI.11 These findings suggest that accumulation of lympho-
cytes with protective properties in the post-ischemic kidney
may mediate IPC.
Regulatory T (Treg) cells are anti-inflammatory lympho-
cytes that have been recently identified in normal mouse
kidneys.15–17 Expression of the interleukin-2 (IL-2) receptor
(CD25) and the transcription factor FoxP3 identify a highly
suppressive subset of CD4þ Treg cells. These lymphocytes
use multiple mechanisms to inhibit the function and
proliferation of pro-inflammatory leukocytes, including
production of IL-10 and/or transforming growth factor-b,
cell-contact-dependent inhibition or generation of extracel-
lular adenosine.18–22 Another important property of Treg
cells is their propensity to home to areas of ongoing
inflammation.23,24
We hypothesized that ischemia/reperfusion would cause
Treg cell accumulation in the kidney as a consequence of
the associated inflammation, which in turn would protect
the kidney from subsequent ischemia/reperfusion-induced
inflammation and kidney injury.
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RESULTS
IPC preserves kidney function and histology after IRI
C57Bl/6 mice underwent 24min of bilateral renal ischemia
(preconditioning) or sham surgery (non-preconditioned
controls) on day 0 and then were allowed to recover for 7
days. On day 7, both groups of mice underwent 28min
bilateral renal ischemia. At 24 h after the initial surgery,
preconditioned mice exhibited a slight, but significant,
decrease in renal function compared to non-preconditioned
control mice, as measured by plasma creatinine (PCr) levels
(Figure 1a). By 72 h of reperfusion, no differences were
observed in PCr levels between groups (Figure 1a). At 24 h
after 28min IRI, non-preconditioned mice (sham/IRI) had
severely decreased renal function, whereas preconditioned
mice (IRI/IRI) were completely protected (Figure 1a). The
increase in outer medulla acute tubular necrosis (ATN)
observed in non-preconditioned mice after 28min IRI was
significantly reduced by IPC (Figure 1b–e).
IPC prevents innate immune cell accumulation in the kidney
after ischemia/reperfusion
At 24 h after the second surgery, accumulation of neutrophils,
macrophages, CD4þ T cells and B cells was assessed by flow
cytometry. Neutrophil (CD45þ7-AADCD11bþGR-1high)
and macrophage (CD45þ7-AADF4/80intLy6Cþ ) numbers
were markedly increased in the kidney after 28min IRI in
non-preconditioned mice (sham/IRI, Figure 2a and b). The
increase in innate inflammatory leukocytes was significantly
attenuated by IPC (IRI/IRI, Figure 2a and b). In contrast,
the number of B cells (CD45þ7-AADB220þCD19þ ) in
kidneys was significantly increased in the preconditioned
mice vs non-preconditioned mice, after 28min IRI (B cells
per gram kidney: 66,000±13,000 vs 150,000±38,000,
n¼ 7, Po0.05). The number of CD4þ T cells (CD45þ7-
AADCD4þSSClow) in kidneys tended to be higher in the
preconditioned mice vs non-preconditioned mice, after
28min IRI, although this difference was not statistically
significant (CD4þ T cells per gram kidney: 106,000±32,000
vs 172,000±36,000, n¼ 10, P40.05). Immunohistochemical
analysis of frozen kidney sections using an antibody that
recognizes neutrophils and recently emigrated monocytes
(7/4; Henderson et al.25 and Taylor et al.26) confirmed the
protective effect of IPC on innate leukocyte accumulation
after IRI (Figure 2c–e).
IRI promotes kidney Treg cell accumulation and enhances
kidney Treg cell IL-10 production
On the basis of the previously demonstrated ability of Treg
cells to traffic to areas of inflammation,23,24 we hypothesized
that kidney IRI would cause accumulation of Treg cells in
the kidney. To test this, we measured the number of Treg
cells in kidneys from mice at various time points after either
sham surgery or 24min bilateral renal ischemia by flow
cytometry. Compared to sham-operated mice, we observed
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Figure 1 | Ischemic preconditioning prevents ischemia/reperfusion-induced kidney dysfunction and acute tubular necrosis. C57Bl/6
mice underwent sham surgery or bilateral renal pedicle clamping (IRI) for 24min on day 0 and were allowed to recover for 7 days. On day 7
mice underwent 28min IRI. Plasma creatinine was measured periodically to assess renal function (a). At 24 h after the second surgery,
kidney sections were fixed and stained with H&E to assess outer medulla acute tubular necrosis in the different treatment groups (b),
pictures are representative of at least eight mice per group (c–e). Data are presented as the mean±s.e.m.; *Po0.01 compared to sham/
sham control group; #Po0.01 compared to sham/IRI, non-preconditioned group. H&E, hematoxylin and eosin; IRI, ischemia/reperfusion
injury.
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an approximately threefold increase in the number of
CD4þCD25þFoxP3þ Treg cells in the kidney 7 days after
IRI (Figure 3). The accumulation of Treg cells appeared to be
kidney specific, because no difference in the number of these
lymphocytes was observed in the spleen. The observed
increase in kidney Treg cell number was delayed and transient
as no increase was noted at 3 or 14 days after IRI (Figure 3).
This is consistent with the finding that preconditioning was
incomplete at day 3. PCr was 0.16±0.05 vs 0.33±0.03mg/dl
for sham/sham vs IRI/IRI, respectively (Po0.05), when
preconditioned mice underwent 28min IRI at day 3, and
0.17±0.03 vs 0.26±0.02mg/dl for sham/sham vs IRI/IRI,
respectively (P¼not significant), when preconditioned mice
underwent 28min IRI at day 7. To investigate the location of
the accumulating Treg cells in the kidney, we performed
immunohistochemical analysis with antibodies to CD4 and
FoxP3. This revealed that CD4þFoxP3þ Treg cells were
observed at similar frequencies inside kidney vascular
structures in both sham-operated and post-ischemic kidneys
(data not shown), but Treg cells were observed in the
outer medulla interstitium only in post-ischemic kidneys
(Figure 3b–d). To determine whether preconditioning
also induces phenotypic changes in Treg cells, we performed
intracellular cytokine staining on kidney CD4þCD25þ Treg
cells for IL-10. Compared to Treg cells from non-precondi-
tioned mouse kidneys, a greater percentage of Treg cells
in kidneys of preconditioned mice expressed IL-10 (Figure 4).
This increase in percentage translates into a more than
eightfold increase in the number of IL-10þ Treg cells per
kidney in preconditioned mice.
Treg cell depletion inhibits the anti-inflammatory effect of IPC
To address the function of Treg cells in the protection
afforded by kidney IPC, we used a monoclonal antibody to
CD25, which is highly expressed on Treg cells. Along with
others, we have used this antibody (PC61) to specifically
decrease CD4þCD25þFoxP3þ Treg cells in C57Bl/6
mice.17,27,28 On day 2 after the initial 24min IRI, precondi-
tioned mice were injected with PC61 or control IgG (300 mg,
i.v.; Figure 5a). To test the effectiveness and specificity of this
treatment, we killed some antibody-treated, preconditioned
mice at day 7 after the initial preconditioning surgery and
measured kidney Treg cell numbers, as well as other leukocyte
subsets from kidney and spleen, by flow cytometry. Similar
to our previous experience with PC61,17 we did not detect
any difference, between preconditioned mice injected with
control IgG or PC61, in kidney neutrophils, macrophages
or dendritic cells, spleen B cells, CD4þ or CD8þ T cells, NK
or NKT cells measured at 5 days after injection (day 7 of the
preconditioning protocol, Figure 5a, data not shown). We did
detect a significant decrease (B50%) in kidney Treg cell
number in PC61-treated preconditioned mice compared to
IgG-treated preconditioned mice (Figure 5b). As previously
reported, PC61 also significantly reduced spleen Treg cell
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Figure 2 | Ischemic preconditioning inhibits innate leukocyte accumulation after IRI. At 24 h after the second surgery, kidneys were
harvested, digested, and stained with neutrophil or macrophage markers and analyzed by flow cytometry as described in the Materials
and Methods section. The absolute number of neutrophils (a) and macrophages (b) per gram kidney in each group is represented graphically.
Frozen kidney sections were stained with an antibody that recognizes neutrophils and recently emigrated monocytes (7/4) to assess
renal accumulation in the different treatment groups, pictures are representative of at least three mice per group (c–e). Data are presented
as the meanþ s.e.m.; *Po0.01 compared to sham/sham, control mice; #Po0.05 compared to sham/IRI, non-preconditioned group.
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numbers by approximately 50% (Kinsey et al.,17 data not
shown). Injection of control IgG neither had any effect on the
neutrophil and macrophage accumulation induced by 28min
IRI in non-preconditioned mice nor the inhibitory effect of
IPC on the inflammatory leukocyte accumulation (Figure 6a
and b). In contrast, decreasing the number of Treg cells
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Figure 3 |Kidney ischemia/reperfusion injury causes kidney Treg cell accumulation. At 3, 7, and 14 days after 24min IRI
(preconditioned) or sham (non-preconditioned) surgery, mouse kidneys and spleen were harvested, digested, and stained for Treg cell
markers as described in the Materials and Methods section. The absolute number of Treg cells per gram in preconditioned mice is
represented as a percentage of their respective sham control (a). Data are presented as the meanþ s.e.m.; *Po0.05, compared to non-
preconditioned mice, n¼ 4–8 per group. Frozen sections from sham-operated (b) or 24min IRI (c, d) kidneys were stained with anti-mouse
CD4 (red) and anti-mouse FoxP3 (green) antibodies. Images are from the outer medulla and are representative of at least three animals in
each group. Treg, regulatory T.
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Figure 4 |Kidney ischemia/reperfusion injury causes increased IL-10 production by kidney Treg cells. At 7 days after 24min IRI
(preconditioned) or sham (non-preconditioned) surgery, mouse kidneys were harvested, digested, and stained for Treg cell-surface markers
CD4 and CD25, and stained for intracellular IL-10 as described in the Materials and Methods section. The percentage (a) and absolute
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compared to non-preconditioned mice, n¼ 6 per group. Treg, regulatory T.
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in preconditioned mice inhibited the ability of IPC to
prevent neutrophil and macrophage accumulation after IRI
(Figure 6a and b).
Treg cell depletion inhibits the kidney functional and
histological protection of IPC
Treatment with PC61 had no effect on the recovery from the
initial preconditioning surgery when measured at day 7.
Renal function in non-preconditioned or preconditioned
mice treated with either IgG or PC61 was no different on day
7, before the induction of 28min bilateral renal ischemia
(Figure 7a). Similarly, renal histology was not significantly
different on day 7 between preconditioned mice treated with
IgG or PC61; outer medulla ATN scores in IgG vs PC61 were
1.2±0.4 and 0.7±0.1, respectively (P40.05). In contrast,
24 h after 28min ischemia (day 8) the non-preconditioned
IgG-treated mice (sham/IRI-IgG) exhibited a severe decline
in renal function, whereas preconditioned IgG-treated mice
(IRI/IRI-IgG) retained normal renal function, as measured
by PCr levels (Figure 7a). Partial Treg cell depletion, in
preconditioned mice (IRI/IRI-PC61), significantly inhibited
the protective effect of IPC on renal function after IRI (Figure
7a). Histological analysis of outer medulla ATN was
consistent with functional observations, revealing a partial
block of the protective effect of IPC on ATN by decreasing
Treg cell numbers in preconditioned mice (Figure 7b and c).
Outer medulla ATN scores in preconditioned mice treated
with IgG vs PC61 were 1.0±0.2 and 2.6±0.3, respectively
(Po0.05).
Adoptive transfer of Treg cells protects the kidney from
subsequent IRI and inflammation
To test the ability of increasing Treg numbers in mice to
protect the kidney from IRI, we performed adoptive transfer
of 1 105 or 1 106 Treg cells (CD4þCD25þ ) or 1 106
non-Treg lymphocytes (CD4þCD25) isolated from WT
C57Bl/6 mice to naive WT C57Bl/6 recipients 18 h before
28min bilateral renal ischemia. The freshly isolated Treg cells
highly expressed FoxP3, as previously described (Kinsey
et al.,17 data not shown). The mice that received 1 106
CD4þCD25 non-Treg lymphocytes before IRI exhibited a
loss of kidney function (Figure 8a) and marked accumulation
of neutrophils and macrophages (Figure 9) compared to
sham-operated controls. Adoptive transfer of 1 105 Treg
cells partially inhibited neutrophil accumulation and pre-
served renal function, and 1 106 Treg cells completely
blocked the loss of function and neutrophil and macrophage
accumulation induced by IRI (Figures 8 and 9). Adoptive
transfer of Treg cells had a dose-dependent protective effect
on ATN (Figure 8b–e). Outer medulla 7/4 staining confirmed
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the flow cytometry results showing dose-dependent protec-
tion from IRI-induced inflammation in the mice receiving
Treg cells (Figure 9c–e).
DISCUSSION
IPC is a powerful technique to protect organs, including the
kidney, from IRI. In this study, we have shown that delayed
kidney IPC specifically inhibits the innate inflammation
(kidney neutrophil and macrophage accumulation) asso-
ciated with kidney IRI. We also report the novel finding that
mild kidney IRI induces a delayed increase in the number of
FoxP3þ and IL-10þ Treg cells in the kidney, such that at the
time of the subsequent more severe renal IRI, preconditioned
mice have threefold more FoxP3þ and eightfold more IL-
10þ Treg cells in the kidney than non-preconditioned mice.
In support of a protective function for Treg cells in IPC,
partial Treg depletion reversed the anti-inflammatory effects
of delayed IPC and significantly inhibited the functional and
histological protection. Finally, adoptive transfer of Treg cells,
before IRI in naive mice mimicked IPC in terms of blocking
inflammation and preventing renal injury.
There are two methods to induce IPC in the kidney. One
type is induced by repeated short ischemic times followed by
periods of reperfusion (for example, 4 cycles of 5min
ischemia and 5min reperfusion). This type of precondition-
ing partially protects the kidney from 30min of ischemia
immediately after the last preconditioning cycle and at 24 h
after the last cycle, but not at 6 h after preconditioning.29
Delayed kidney IPC involves a longer single initial ischemic
time (that is,420min) followed by a recovery period of 6–8
days.11,14 After this procedure, mice are completely protected
from subsequent ischemic injury for more than 1 week and
partially protected for up to 12 weeks.14 We used a model of
delayed IPC that resulted in complete functional protection
of the kidney from severe ischemic injury 7 days after the
initial preconditioning surgery. This model of IPC markedly
decreased the infiltration of neutrophils and macrophages in
the post-ischemic kidney, which are both known to cause
renal injury.5–10
A report from Ascon et al.30 showed that adoptive transfer
of lymphocytes from kidneys of preconditioned mice
conferred protection against renal IRI in naive T-cell-
deficient mice, suggesting that renal IRI causes kidney
accumulation of lymphocytes with a protective (potentially
anti-inflammatory) phenotype. Characterization of the
specific lymphocyte (T or B cell) subset(s) responsible for
the protection was not reported. We hypothesized that the
highly immunosuppressive CD4þCD25þ Treg cells (expres-
sing FoxP3þ and/or IL-10) could be important mediators
of kidney IPC for several reasons. First, we have recently
shown that CD4þCD25þFoxP3þ Treg cells are an intrinsic
protective mechanism against kidney IRI in naive mice,
which directly and potently block the innate immune
response to IRI.17 Second, WT, but not IL-10 KO, Treg cells
could suppress IRI in lymphocyte-deficient RAG-1 KO mice.17
Furthermore, the trafficking and accumulation of Treg cells
in areas of ongoing inflammation has been documented in
other models.23,24 We found that the initial ischemic insult in
our preconditioning model resulted in a kidney-specific
increase in the number of kidney CD4þCD25þFoxP3þ Treg
cells and the number and percentage of CD4þCD25þ Treg
cells expressing IL-10 in the kidney. Our findings are in
agreement with a recent report from Gandolfo et al.16 showing
renal accumulation of Treg cells after more severe IRI. The
preconditioned mice, which were completely protected from
ischemic injury, possessed significantly more kidney Treg cells
than non-preconditioned mice that were susceptible to IRI. In
addition, the localization of the Treg cells in the precondi-
tioned kidneys was distinct, in that Treg cells were consistently
observed in the outer medulla interstitium (which is also the
area of the most extensive inflammation and tubular necrosis
after kidney IRI). In summary, the preconditioned kidney
has a larger population of anti-inflammatory Treg cells and
they are located in the most ischemia-susceptible region of the
kidney, the outer medulla.
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Figure 9 |Adoptive transfer of Treg cells prevents ischemia/reperfusion-induced inflammation. At 18 h before 28min bilateral renal
ischemia, naive C57Bl/6 mice were administered either 1 106 CD4þCD25 non-Treg lymphocytes (CD25), 1 105, or 1 106
CD4þCD25þ Treg cells by tail vein injection. At 24 h after sham surgery or IRI, kidney neutrophil (a) and macrophage (b) accumulation was
measured by flow cytometry. Frozen kidney sections were stained with an antibody that recognizes neutrophils and recently emigrated
monocytes (7/4) to assess renal accumulation in the different treatment groups (c–e). Data are presented as the meanþ s.e.m., means with
different labels are significantly different from each other, Po0.01. IRI, ischemia/reperfusion injury; ND, not done; Treg, regulatory T.
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To determine the function of Treg cells in kidney IPC, we
administered the Treg cell-depleting antibody, PC61 to
preconditioned mice, resulting in a B50% reduction in
Treg cell numbers, compared to control IgG-treated pre-
conditioned mice, at the time of the second ischemic insult.
Decreasing Treg cell numbers, in preconditioned mice,
caused inhibition of the anti-inflammatory effect of IPC
and partially blocked the functional and histological protec-
tion. These results reveal an important function for Treg cells
in kidney IPC. The finding that mice are not completely
protected from IRI-induced dysfunction at 3 days after the
initial preconditioning surgery (before kidney Treg cell
accumulation) adds additional support for the contribution
of Treg cells to the protection of IPC.
Although Treg cell-deficient mice, FoxP3-deficient Scurfy
mice, are available, they develop extensive autoimmune
disease and early death,31 precluding their use in our studies.
Furthermore, our goal was to test the effectiveness of IPC
in kidneys that contained the basal number of Treg cells
found in non-preconditioned mice. We were able to create
these conditions in two ways: (1) use of preconditioned mice
3 days after the initial surgery and before the increase in
kidney Treg cell numbers, and (2) by treating preconditioned
mice with PC61 to reduce the number of kidney Treg cells
at 7 days after the initial surgery. Both methods resulted
in partial reversal of the functional protection of IPC.
Other immune cells may participate in kidney precondi-
tioning based on studies that have shown their function
in kidney IRI or in actual preconditioning. B cells do
accumulate in the post-ischemic kidney9 and may have a
pathogenic function in kidney IRI.3 However, no studies
have examined their function in preconditioning. Although
macrophage infiltration may contribute to the recovery after
kidney injury, they do not contribute to IPC in kidneys.32 To
our knowledge, there are no studies showing a function for
neutrophils in IPC in kidneys. Further studies that focus on
immune cells may reveal additional mechanisms of IPC.
While our results show that Treg cells are important
mediators of the anti-inflammatory action of IPC, other
mechanisms protect the preconditioned kidney, even in the
presence of extensive inflammatory leukocyte accumulation.
In delayed kidney IPC, several nonimmune mechanisms
have been previously described, including upregulation of
the renal pro-survival signals HSP 27 expression14 and Akt
phosphorylation,13 and decreased phosphorylation of cell-
death-promoting p38 and Jun kinase.14 These changes
presumably occur in the epithelial and endothelial cells
of the preconditioned kidney and make them more resistant
to ischemia and inflammatory mediator-induced toxicity
(reactive oxygen species, proteases, and so on), leading to the
substantial residual protection observed in preconditioned
mice treated with PC61.
Our aim in studying IPC was to discover novel and less-
invasive strategies to protect the kidney from IRI. As a first
step in this direction, we assessed the effectiveness of adoptive
transfer of Treg cells to a naive WT recipient before kidney
IRI. We found that, in contrast to an equivalent number of
non-Treg CD4þ lymphocytes, Treg cells could completely
inhibit inflammation and renal dysfunction induced by
severe bilateral renal ischemia. These results complement our
previous finding that Treg cells, but not non-Treg lympho-
cytes, can inhibit renal neutrophil accumulation and IRI
in lymphocyte-deficient RAG-1 KO mice.17 Therefore, in the
presence or absence of other leukocytes, Treg cells suppress
the innate inflammation and subsequent loss of function
induced by kidney ischemia/reperfusion. Our findings
suggest that adoptive transfer or pharmacological induction
of Treg cells may represent less-invasive methods to protect
organs from ischemic insult.
The source of the renal Treg cells, accumulating after IRI,
is not currently known. At least two different explanations
are possible, which are not mutually exclusive. First, existing
Treg cells from the circulation could be recruited to the post-
ischemic kidney by chemokines. The CCR2 chemokine
receptor directs Treg cells toward arthritic joints.33 Monocyte
chemoattractant protein-1 (MCP-1/CCL-2) is the major
ligand for CCR2 and the expression of this chemokine is
highly upregulated in the kidney after IRI.34,35 A second
potential source of the Treg cells could be kidney non-Treg
lymphocytes, activated by T-cell receptor stimulation in the
presence of transforming growth factor-b, which has been
shown to induce FoxP3 expression and a suppressive
phenotype.36 Although transforming growth factor-b is
produced in the kidney after ischemia,37 so is IL-6,38 and
the combination of these two cytokines promotes the
induction of Th17 cells rather than Treg cells.39 However,
the time course and the intra-kidney differences in
concentrations of these cytokines may still permit the
induction of Treg cells in the post-ischemic kidney. The
origin of Treg cells accumulating after IRI is under
investigation and may lead to more specific ways to mimic
IPC in different organs.
In summary, IPC markedly inhibits inflammation, ATN, and
loss of function induced by ischemia/reperfusion.
We show that the initial ischemic insult (preconditioning)
causes a kidney-specific increase in Treg cells, such that the
preconditioned kidney has several-fold more Treg cells
than non-preconditioned kidneys. Partial depletion of Treg cells
in preconditioned mice restores the accumulation of neutrophils
and macrophages, induced by IRI, and partially reverses
functional and histological protection. Finally, increasing Treg
cell numbers in WTmice, by adoptive transfer, mimics the anti-
inflammatory and renal protective effects of IPC. Taken together,
these results suggest that strategies designed to increase Treg cells
may represent a novel therapy for IRI.
MATERIALS AND METHODS
Mice and adoptive transfer
Male C57Bl/6 mice, 6–8 weeks of age and weighing 20–25 g, were
obtained from Charles River Laboratories (Wilmington, MA).
CD4þCD25þ Treg cells and CD4þCD25 non-Treg lymphocytes
were isolated from WT C57Bl/6 mice using the Dynal (Carlsbad,
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CA) CD4þ negative selection kit and Miltenyi Biotec (Auburn, CA)
CD25þ positive selection kit according to manufacturer’s protocol
as previously described.17 Cells were adoptively transferred by tail
vein injection in 200 ml normal saline.
Surgical protocol
For the renal IRI protocol, both renal pedicles were exposed
and cross-clamped for 24 or 28min as previously described by
our laboratory.7,9,17 All animal experiments were approved by the
University of Virginia Institutional Animal Care and Use Committee.
Assessment of renal function and histology after IRI
PCr and outer medulla tubular necrosis were assessed as previously
described.7,9,17
Characterization of kidney leukocytes after IRI
Five-color flow cytometry was used to determine the number
and phenotype of leukocytes in the kidney. Counting beads
(Caltag, Carlsbad, CA) were used as described previously7,9,17 to
determine the total number of CD45þ cells per gram kidney.
CD4þCD25þFoxP3þ Treg cells were stained, fixed, and permea-
bilized using the eBioscience (San Diego, CA) FoxP3 buffer set
according to the manufacturer’s protocol as previously described.17
Anti-mouse fluorophore-labeled antibodies and dead cell stains used
have been described previously.17
Intracellular cytokine staining was performed for IL-10. Kidneys
were harvested and digested with collagenase as previously de-
scribed.7,9,17 The kidney cell suspension was enriched for mononuclear
cells by layering the suspension (in 5ml ice-cold phosphate-buffered
saline) on top of 2.5ml Histopaque (Sigma, St Louis, MO, USA) and
centrifuging at 230 g for 20min. Cells residing at the interface of
phosphate-buffered saline and Histopaque were recovered and washed
2 with phosphate-buffered saline. Cells were incubated 5 h at 37 1C
in RPMI 1640 (Gibco, Carlsbad, CA, USA)þ 10% fetal bovine serum,
penicillin/streptomycin, and 50mmol/l b-mercaptoethanol at 2 million
cells per 2ml and treated with leukocyte activation cocktail
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s
protocol. Extracellular staining was performed as described above for
CD45, 7-AAD, CD4, and CD25, then cells were fixed and
permeabilized using the BD Cytofix/perm kit according to the
manufacturer’s protocol and stained with 0.2mg per sample a-mouse
IL-10 APC (clone JES5-16E3; BD Biosciences, San Jose, CA, USA).
Immunohistochemical analysis of innate leukocytes and Treg
cells in the kidney
Kidneys were fixed overnight in 1% PLP, incubated for 48 h in 30%
sucrose at 4 1C, then embedded and frozen in Optimal Cutting
Temperature compound (OCT; Ted Pella, Redding, CA). Frozen
kidney sections (10 mm) from each mouse were blocked with goat
serum and 2.4G2, then labeled with Treg-specific antibodies, CD4-
PE and FoxP3-Alexa Fluor 647, or FITC-conjugated neutrophil/
monocyte-specific antibody (clone 7/4; Cedarlane, Hornby, Ontario,
Canada). Nuclei were visualized using DAPI. Specimens were
mounted with ProLong Gold Antifade reagent (Molecular Probes,
Eugene, OR) and examined using a Zeiss (Thornwood, NY, USA)
Axiovert 200 microscope with ApoTome.
Antibody-mediated Treg cell depletion
The TIB-222 hybridoma was used by the Lymphocyte Culture Core
Facility at the University of Virginia to produce the anti-mouse
CD25 monoclonal antibody (clone PC61). Rat IgG isotype control,
ImmunoPure Rat IgG, was purchased from Pierce (Rockford, IL).
Statistical analysis
Comparisons of two treatment groups were made using an unpaired
t-test to determine statistical significance unless a normality test
failed, in which case the Mann–Whitney rank sum test was
performed. Analysis of variance was performed for comparisons
of three or more groups and the Holm–Sidak procedure used for
pair-wise comparisons using the SigmaStat statistical software
(Systat Software, Inc., Chicago, IL, USA). A P-value of o0.05 was
considered statistically significant.
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